MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 129 filers reported holding MACROGENICS INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,872 | -0.5% | 402 | +14.2% | 0.00% | – |
| Q2 2023 | $1,882 | -99.4% | 352 | -99.2% | 0.00% | -100.0% |
| Q1 2023 | $321,057 | -51.4% | 44,778 | -54.6% | 0.00% | 0.0% |
| Q4 2022 | $661,000 | +32950.0% | 98,646 | +18442.5% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 532 | +33.0% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 400 | -48.7% | 0.00% | – |
| Q1 2022 | $6,000 | -66.7% | 780 | -33.3% | 0.00% | – |
| Q4 2021 | $18,000 | -50.0% | 1,169 | -33.4% | 0.00% | – |
| Q3 2021 | $36,000 | -53.8% | 1,755 | -38.8% | 0.00% | – |
| Q2 2021 | $78,000 | -13.3% | 2,867 | +1.4% | 0.00% | – |
| Q1 2021 | $90,000 | +190.3% | 2,827 | +107.6% | 0.00% | – |
| Q4 2020 | $31,000 | +121.4% | 1,362 | +145.8% | 0.00% | – |
| Q3 2020 | $14,000 | -12.5% | 554 | 0.0% | 0.00% | – |
| Q2 2020 | $16,000 | -27.3% | 554 | -85.8% | 0.00% | – |
| Q1 2020 | $22,000 | – | 3,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |